The following are the seven risks that, in this analyst's assessment, are most material to the investment case. They are ranked roughly by severity — from existential threats to material headwinds.

ARDP Funding Dependency and Extension Risk (Existential). The ARDP current budget period runs only through August 2026, with extensions requiring sequential DOE Continuation Application approvals. The maximum ARDP period of performance is 10 years from the February 2021 award, implying an outside date of approximately 2031 — before the Dow project is expected to achieve commercial operations. If the timeline extends beyond ARDP coverage, Dow bears construction costs without the 50% government cost-share. As of December 31, 2025, X-energy has received approximately $438 million of the $1.2 billion total committed ARDP reimbursement.¹
No Final Investment Decisions Received (Existential). X-energy has not received an FID from any customer. Dow can terminate its MPDA and CCA at any time for convenience, with no obligation to compensate X-energy for loss of the ARDP project. X-energy itself has no obligation to fund construction without Dow's FID. The Centrica JDA is explicitly non-binding and does not commit either party to any capital or definitive agreements.¹
Technology Fee and Commercial Agreement Execution (Structural). The entire long-term business model is predicated on technology fee and services agreements not yet signed. Customers may resist paying licensing fees on top of substantial construction capital expenditures. Management acknowledges benchmarking fees against other industries may not translate to nuclear project economics where Dow and Amazon are large, sophisticated counterparties with significant negotiating leverage.¹
HALEU Supply Chain (Structural). The Xe-100 requires HALEU enriched to 15.5%, a level with no established commercial supply chain outside government sources. Commercial enrichers do not yet produce HALEU at scale and require NRC licensing to do so. If commercial HALEU supply fails to materialize on the required timeline, TX-1 operations and reactor deployments could be significantly delayed.¹
First-of-a-Kind Construction Cost and Schedule Risk (Headwind). The nuclear industry has a structural history of FOAK cost overruns. Vogtle Units 3 and 4 cost more than $16 billion each and ran seven years over schedule. X-energy's S-1 acknowledges its current cost model has limited fidelity and that estimated project costs have already increased from the original 2020 ARDP baseline and are expected to continue increasing. NOAK cost savings of 30%+ are projected but historically difficult to achieve in nuclear construction.¹
Regulatory and Intervention Risk (Headwind). The Dow CPA is subject to a pending Waterkeeper petition, with two contentions admitted for litigation by the NRC's Atomic Safety and Licensing Board as of January 22, 2026. The adjudicatory proceeding adds cost and could extend the review timeline. NRC staffing constraints and a growing application backlog may further slow reviews for subsequent projects. Any delay in the Dow CPA receipt beyond Q1 2027 directly delays construction and the Dow FID.¹
Material Weakness in Internal Controls (Governance). The S-1 discloses that X-energy has identified material weaknesses in internal control over financial reporting. Failure to remediate existing weaknesses or maintain effective public-company-grade controls could adversely affect financial reporting integrity and investor confidence post-listing.¹

X-Energy IPO: A Government-Funded R&D Startup Betting on a Trillion-Dollar Commercial Nuclear Transition

The Power Delivery Gap